The potential role of adjunctive bone-protective therapies - including calcium and vitamin D supplementation, weight-bearing exercise, and, in selected high-risk cases, pharmacologic agents such as bisphosphonates - should be considered on an individual basis, though no evidence specifically addresses this question in MC4R -deficient patients
GLP-1 medications help reverse these patterns
Following any protocol here does not create a doctor-patient relationship, and no provider-patient relationship is intended
In a large-scale study conducted in adult epilepsy patients in Japan, HA was found in 43% of the cohort, with 40.7% of them presenting with symptomatic HA requiring treatment with carnitine rescue, intravenous therapy or VPA dose reduction [6]
To date, none of these markers has provided approximations of -cell mass with sufficient sensitivity and specificity to justify their routine application in humans